Parawatan untuak kanker paru-paru bagantuang pado babarapo faktor, tamasuak stadium kanker, jinih kanker paru-paru, jo kasihatan umum pasien.
Babarapo pilihan pangobatan nan umum adolah:
1. Operasi: Iko acoknyo adolah caro perawatan nan disukoi untuak kanker paru-paru tahap awal.
Para ahli bedah mangaluakan tumor jo saketek jaringan sehat di sakitarnyo.
2. Terapi radiasi: Radiasi energi tinggi digunokan untuak mambunuah sel kanker jo mangurangi tumor.
Ubek ko dapek digunokan surang atau digabung jo ubek lain.
3. Kemoterapi: Pangobatan iko manggunokan ubek untuak mambunuah sel kanker.
Ubek ko dapek diagiah intravena atau sacaro muluik, dan acok digunokan basamo jo pangobatan lain.
4. Terapi nan diarahkan: Terapi iko diarahkan pado gen atau protein tatantu nan bakontribusi pado patumbuahan jo batahan iduik sel kanker.
Ubek ko acok digunokan untuak kanker paru-paru nan alah maningkek atau nan alah manyeba.
5. Imunoterapi: Pangobatan iko mambantu sistem imun untuak mangenali jo manyarang sel kanker.
Ubek ko acok digunokan untuak kanker paru-paru nan alah maningkek atau nan alah manyeba.
6. Terapi fotodinamis: Pangobatan iko manggunokan ubek nan diaktifkan dek cahayo untuak mambunuah sel kanker.
Ubek ko acok digunokan untuak kanker paru-paru tahap awal.
7. Terapi proton: iko adolah jinih terapi radiasi nan manggunokan proton untuak mangirim radiasi ka tumor.
Ubek ko acok digunokan untuak kanker paru-paru tahap awal.
8. Uji klinis: Pasien mungkin layak untuak sato dalam uji klinis untuak mancubo-cubo pangobatan baru atau kombinasi pangobatan.
Paralu untuak mambicarokan pilihan pangobatan nan paliang baiak jo tim kasihatan, karano rencana pangobatan nan paliang efektif tagantuang pado situasi spesifik individu.
Chen JH, Wu J, Xu Q: The emerging treatment landscape of targeted therapy in non-small-cell lung cancer. Signal Transduct Target Ther. , 4 (): 61.
Furuse K: [Photodynamic therapy of centrally located early-stage lung cancer]. Gan To Kagaku Ryoho. 1996, 23 (1): 27-30.
Gálffy G: [From rare mutations to classical ones, inhibition of signaling pathways in non-small cell lung cancer]. Magy Onkol. 2020, 64 (3): 196-204.
Magalhães M, Alvarez-Lorenzo C, Concheiro A, Figueiras A, Santos AC, Veiga F: RNAi-based therapeutics for lung cancer: biomarkers, microRNAs, and nanocarriers. Expert Opin Drug Deliv. 2018, 15 (10): 965-982.
Kataoka M, Fujiwara T, Tanaka N: [Gene therapy for lung cancer]. Nihon Geka Gakkai Zasshi. 2002, 103 (2): 244-9.
Jin C, Yang B: A Case of Delayed Diagnostic Pulmonary Tuberculosis during Targeted Therapy in an EGFR Mutant Non-Small Cell Lung Cancer Patient. Case Rep Oncol. , 14 (1): 659-663.
Wang Y, Liu Q, Chen H, You J, Peng B, Cao F, Zhang X, Chen Q, Uzan G, Xu L, Zhang D: Celastrol improves the therapeutic efficacy of EGFR-TKIs for non-small-cell lung cancer by overcoming EGFR T790M drug resistance. Anticancer Drugs. 2018, 29 (8): 748-755.
['Disclaimer: medis']
['Situs web iko hanyo digunokan untuak tujuan pandidikan jo informasi sajo dan indak mambari nasehat medis atau layanan profesional.']
['Informasi nan disadioan indak buliah digunoan untuak mandiagnosis atau maubek masalah kasihatan atau panyakik, dan urang nan mancari nasehat medis pribadi harus bakonsultasi jo dotor nan balisensi.']
['Tolong diingek jaringan saraf nan manghasilkan jawaban untuak pertanyaan, khususnyo indak akurat katiko datang ka isi numerik. contohnyo, jumlah urang nan didiagnosis jo panyakik tatantu.']
['Salalu mintak nasehat dotor atau panyadia kasihatan lain nan kualifikasi manganai kondisi medis. Jan pernah maabaikan nasehat medis profesional atau talambek dalam mamintaknyo dek karano sasuatu nan awak baco di situs web iko. Jiko awak sangko mungkin ado kaadaan darurat medis, hubungi 911 atau pai ka ruang gawat darurat paliang dakek lansuang. Indak ado hubungan dotor-pasien nan diciptaan dek situs web iko atau panggunoannyo. BioMedLib maupun karyawan, maupun kontributor situs web iko, indak ado malakukan representasi, jaleh atau tasuruak, manganai informasi nan disadioan di siko atau panggunoannyo.']
['Panyalasaian: hak cipta']
['Digital Millennium Copyright Act of 1998, 17 U.S.C. § 512 (DMCA) manyadiokan jalan bagi pamilik hak cipta nan picayo bahwasanyo bahan nan muncul di Internet malangga haknyo manuruik hukum hak cipta AS. ']
['Jiko Sanak yakin jo yakin baso isi atau bahan nan tasadio dalam pautan ka situs web atau layanan kami malangga hak cipta Sanak, Sanak (atau agen Sanak) dapek mangirim kami pasan mamintak untuak manghapuih isi atau bahan tasabuik, atau mamblokir akses ka situs tasabuik. ']
['Kabar harus dikirim sacaro tulisan malalui surel (caliak bagian "Kontak" untuak alamat surel).']
['DMCA mamaraluan supayo pasan pasan palanggaran hak cipta nan didakwa tamasuak informasi barikuik: (1) deskripsi karya hak cipta nan manjadi subyek palanggaran nan didakwa; (2) deskripsi isi nan didakwa malanggar jo informasi nan cukuik untuak mamungkinkan kami untuak manamukan isi; (3) informasi kontak untuak Sanak, tamasuak alamat, nomor telepon jo alamat surel; (4) pernyataan Sanak baso Sanak punyo kayakinan baiak baso isi nan dikaduan indak diizinkan dek nan punyo hak cipta, atau agennyo, atau dek operasi hukum apo pun; ']
['(5) suatu pernyataan nan ditandotangani dek Sanak, jo hukuman sumpah palsu, baso informasi dalam notifikasi tu akurat jo Sanak punyo wewenang untuak manjalankan hak cipta nan dikatokan alah di langgar; ']
['dan (6) ciek tando tangan fisik atau elektronik dari pamilik hak cipta atau sasaurang nan punyo hak untuak batindak ateh namo pamilik hak cipta. ']
['Kok indak tamasuak sado informasi di ateh dapek manyababkan panundaan pangolahan aduan Sanak.']
['Kontak']
['Tolong kirim surel untuak pertanyaan/saran.']
How to treat lung cancer?
The treatment for lung cancer depends on several factors, including the stage of the cancer, the type of lung cancer, and the patient's overall health.
Some common treatment options include:
1. Surgery: This is often the preferred treatment for early-stage lung cancer.
The surgeon removes the tumor and a small portion of healthy tissue around it.
2. Radiation therapy: High-energy radiation is used to kill cancer cells and shrink tumors.
It can be used alone or in combination with other treatments.
3. Chemotherapy: This treatment uses drugs to kill cancer cells.
It can be given intravenously or or orally, and is often used in combination with other treatments.
4. Targeted therapy: This treatment targets specific genes or proteins that contribute to the growth and survival of cancer cells.
It is often used for advanced or metastatic lung cancer.
5. Immunotherapy: This treatment helps the immune system recognize and attack cancer cells.
It is often used for advanced or metastatic lung cancer.
6. Photodynamic therapy: This treatment uses a light-activated drug to kill cancer cells.
It is often used for early-stage lung cancer.
7. Proton therapy: This is a type of radiation therapy that uses protons instead of x-rays to deliver radiation to the tumor.
It is often used for early-stage lung cancer.
8. Clinical trials: Patients may be eligible to participate in clinical trials testing new treatments or combinations of treatments.
It is important to discuss the best treatment options with a healthcare team, as the most effective treatment plan will depend on the individual's specific situation.
Disclaimer: medical
This web site is provided for educational and informational purposes only and does not constitute providing medical advice or professional services.
The information provided should not be used for diagnosing or treating a health problem or disease, and those seeking personal medical advice should consult with a licensed physician.
Please note the neural net that generates answers to the questions, is specially inaccurate when it comes to numeric content. For example, the number of people diagnosed with a specific disease.
Always seek the advice of your doctor or other qualified health provider regarding a medical condition. Never disregard professional medical advice or delay in seeking it because of something you have read on this website. If you think you may have a medical emergency, call 911 or go to the nearest emergency room immediately. No physician-patient relationship is created by this web site or its use. Neither BioMedLib nor its employees, nor any contributor to this web site, makes any representations, express or implied, with respect to the information provided herein or to its use.
Disclaimer: copyright
The Digital Millennium Copyright Act of 1998, 17 U.S.C. § 512 (the “DMCA”) provides recourse for copyright owners who believe that material appearing on the Internet infringes their rights under U.S. copyright law. If you believe in good faith that any content or material made available in connection with our website or services infringes your copyright, you (or your agent) may send us a notice requesting that the content or material be removed, or access to it blocked. Notices must be sent in writing by email (see 'Contact' section for email address) . The DMCA requires that your notice of alleged copyright infringement include the following information: (1) description of the copyrighted work that is the subject of claimed infringement; (2) description of the alleged infringing content and information sufficient to permit us to locate the content; (3) contact information for you, including your address, telephone number and email address; (4) a statement by you that you have a good faith belief that the content in the manner complained of is not authorized by the copyright owner, or its agent, or by the operation of any law; (5) a statement by you, signed under penalty of perjury, that the information in the notification is accurate and that you have the authority to enforce the copyrights that are claimed to be infringed; and (6) a physical or electronic signature of the copyright owner or a person authorized to act on the copyright owner’s behalf. Failure to include all of the above information may result in the delay of the processing of your complaint.
['Sakitarnyo']
['BioMedLib manggunokan komputer otomatis (algoritma machine-learning) untuak mambuek pasangan pertanyaan-jo-jawaban.']
['Kami mamulai jo 35 juta publikasi biomedis dari PubMed/Medline. juo, laman web dari RefinedWeb.']
